What is the recommended dose titration when switching from Adderall (amphetamine/dextroamphetamine) to Vyvanse (lisdexamfetamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from Adderall to Vyvanse: Dose Conversion

There is no established direct dose conversion between Adderall and Vyvanse (lisdexamfetamine), so start Vyvanse at 30 mg once daily in the morning regardless of prior Adderall dose, then titrate in 10-20 mg increments at weekly intervals up to a maximum of 70 mg daily. 1

Recommended Approach

Initial Dosing Strategy

  • Start all patients at 30 mg Vyvanse once daily in the morning, which is the FDA-approved starting dose for ADHD treatment 1
  • This standard starting dose applies regardless of whether the patient was taking 10 mg, 20 mg, or 40 mg of Adderall XR 1
  • Take in the morning with or without food to minimize insomnia 1

Titration Schedule

  • Increase by 10 mg or 20 mg increments at approximately weekly intervals based on clinical response and tolerability 1
  • Allow at least one week between dose increases to properly evaluate therapeutic response 2
  • The maximum recommended dose is 70 mg once daily 1

Rationale for This Approach

The lack of direct conversion stems from fundamental pharmacokinetic differences between these medications:

  • Vyvanse is a prodrug that must be hydrolyzed in the body to release active d-amphetamine, creating a delayed and prolonged release profile 3, 4, 5
  • Vyvanse has a 0.6-1.1 hour longer lag time to reach peak plasma concentrations compared to immediate d-amphetamine 4
  • Despite containing only d-amphetamine (versus Adderall's mixed amphetamine salts), the prodrug mechanism creates different pharmacodynamics that don't allow for simple milligram-to-milligram conversion 4, 5

Clinical Monitoring During Transition

What to Assess Before Each Dose Increase

  • Therapeutic effects: Improvement in ADHD symptoms using standardized rating scales 2
  • Vital signs: Blood pressure and pulse at each visit 2
  • Weight: Monitor at each visit for appetite suppression 2
  • Side effects: Decreased appetite, insomnia, headache, irritability are most common 1, 3

Timeline Expectations

  • Week 1: Start 30 mg, assess tolerability
  • Week 2-6: Titrate upward in 10-20 mg increments weekly as needed 1
  • Efficacy assessment: Full therapeutic effect should be evaluated after reaching stable dose for at least 2 weeks 2

Common Pitfalls to Avoid

  • Don't attempt a direct dose conversion (e.g., switching 30 mg Adderall XR to 30 mg Vyvanse) as this lacks evidence-based support 1
  • Don't start at doses higher than 30 mg even if the patient was on high-dose Adderall, as this increases risk of side effects and poor adherence 2
  • Don't increase doses more frequently than weekly, as insufficient time between increases prevents accurate assessment of therapeutic response 2
  • Don't continue escalating beyond 70 mg if inadequate response occurs; instead consider switching to an alternative medication or adding adjunctive treatment 2
  • Don't dose in the afternoon or evening due to insomnia risk 1

Special Considerations

Why Patients May Need Different Doses

Research shows that 41% of medication-naive adults with ADHD require switching between stimulant families (methylphenidate vs. amphetamine) due to poor tolerability, and this cannot be predicted by baseline characteristics 6. This underscores why standardized titration from a conservative starting dose is necessary rather than attempting dose conversion.

Renal Impairment

  • Severe renal impairment (GFR 15-30): Maximum 50 mg daily 1
  • End-stage renal disease (GFR <15): Maximum 30 mg daily 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.